Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Accelerated atheroma in lupus--background.

M B Urowitz1, D D Gladman

  • 1The University of Toronto Lupus Clinic, Toronto Western Hospital, Ontario, Canada.

Lupus
|May 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?

The British journal of dermatology·2020
Same author

Disease course patterns in systemic lupus erythematosus.

Lupus·2018
Same author

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.

Arthritis research & therapy·2018
Same author

Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.

Arthritis research & therapy·2018
Same author

Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

Lupus·2018
Same author

Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

Lupus·2018
Same journal

Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016-2017.

Lupus·2026
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
See all related articles

Systemic lupus erythematosus (SLE) patients face accelerated atherosclerosis, a major cause of death. Key risks include hypercholesterolemia, hypertension, and lupus itself, with corticosteroids worsening lipid levels.

Area of Science:

  • Rheumatology
  • Cardiology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is linked to accelerated atherosclerosis, a significant cause of mortality and morbidity.
  • Coronary artery disease in premenopausal women with SLE led to the concept of a bimodal mortality pattern, confirmed by epidemiological and autopsy studies.
  • Hypercholesterolemia, hypertension, and SLE disease activity are identified as key risk factors for atherosclerosis in SLE patients.

Purpose of the Study:

  • To review the established risk factors for accelerated atherosclerosis in SLE.
  • To evaluate the impact of corticosteroid and antimalarial therapies on lipid profiles in SLE patients.
  • To compare the prevalence of atherosclerotic disease in SLE using clinical outcomes versus sensitive imaging techniques.

Main Methods:

Related Experiment Videos

  • Observational cohort studies
  • Autopsy and epidemiological studies
  • Clinical outcome assessments (angina, myocardial infarction)
  • Sensitive investigations (myocardial perfusion imaging, carotid ultrasound)

Main Results:

  • Hypercholesterolemia (especially persistent), hypertension, and SLE are significant risk factors for accelerated atherosclerosis.
  • Corticosteroids elevate plasma lipids, while antimalarials reduce cholesterol and LDL, particularly in steroid-induced hyperlipidemia.
  • Clinical studies show 6-12% prevalence of atherosclerotic disease, whereas sensitive imaging reveals a 40% prevalence in SLE patients.

Conclusions:

  • Accelerated atherosclerosis is a critical concern in SLE, influenced by disease activity, traditional risk factors, and medication.
  • Sensitive imaging techniques reveal a higher prevalence of atherosclerosis in SLE patients than previously recognized.
  • Further research into SLE's immunological factors may clarify atherosclerosis pathogenesis in both SLE and the general population.